Furthermore, it has been demonstrated that CELF1 enhances the migratory and invasive capacities of CRC cells, as well as their resistance to chemotherapy via interacting with ETS2 mRNA, ultimately leading to increased expression of ETS2 [73]. This evidence concerns the gene ETS2 and colorectal carcinoma.